The European Commission has approved Servier for LONSURF® in combination with Bevacizumab in Female Patients with refractory metastatic colorectal Cancer

Rüdesheim, SM

ONCOLOGY RESEARCH AND TREATMENT, 2023; 46 (9):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索